OFF-BRAND STI571: A COST-EFFECTIVE OPTION?

The arrival of off-brand imatinib represents a significant chance for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, branded as Gleevec, carries a high price cost, frequently making it accessibility for some